Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.

Abstract

In postmenopausal women receiving adjuvant AIs for HR-positive EBC, a policy of baseline and annual BMD screening followed by selective treatment with oral bisphosphonates for those diagnosed with osteoporosis is a cost-effective use of societal resources.

Full Text

• DOI - Journal of clinical oncology : official journal of the American Society of Clinical Oncology (DOI)
• HighWire Press - full-text online
• EBSCO - full-text online

Subjects

• Absorptiometry, Photon
• Administration, Oral
• Age Factors
• Aromatase Inhibitors
• Bone Density
• Bone Density Conservation Agents
• Bone Diseases, Metabolic
• Breast Neoplasms
• Computer Simulation
• Cost-Benefit Analysis
• Diphosphonates
• Disease-Free Survival
• Drug Costs
• Early Detection of Cancer
• Female
• Fractures, Bone
• Humans
• Markov Chains
• Middle Aged
• Models, Economic
• Neoplasm Staging
• Osteoporosis
• Postmenopause
• Predictive Value of Tests
• Quality-Adjusted Life Years
• Time Factors
• Treatment Outcome

Similar articles

• Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. (2012-06-20)
• Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. (2012-07-25)
• Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. (2004-10-18)
• Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. (2010-02-04)
• Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. (2005-01-26)
• Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer. (2010-10-11)
• The effectiveness of blood tests in detecting secondary osteoporosis or mimicking conditions in postmenopausal women. (2002-04-10)
• Cost-effectiveness of endometrial evaluation prior to morcellation in surgical procedures for prolapse. (2013-03-29)
• Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial. (2007-06-28)
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women. (2013-02-13)

Authors

• Kouta Ito
• Victoria S Blinder
• Elena B Elkin

Publication date

2012-04-30

Journal

Journal topics

• Medical Oncology

Language

Eng.

Copyright

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Brigham and Women’sHospital, Boston, MA, USA. kito5 [at] partners.org

Release reference

J Clin Oncol. 2012 May;30(13):1468-75

Related books

• Books of Absorptiometry, Photon
• Books of Administration, Oral
• Books of Age Factors
• Books of Aromatase Inhibitors
• Books of Bone Density
• Books of Bone Density Conservation Agents
• Books of Bone Diseases, Metabolic
• Books of Breast Neoplasms
• Books of Computer Simulation
• Books of Cost-Benefit Analysis
• Books of Diphosphonates
• Books of Disease-Free Survival
• Books of Drug Costs
• Books of Early Detection of Cancer
• Books of Fractures, Bone
• Books of Markov Chains
• Books of Medical Oncology
• Books of Models, Economic
• Books of Neoplasm Staging
• Books of Osteoporosis
• Books of Postmenopause
• Books of Predictive Value of Tests
• Books of Quality-Adjusted Life Years
• Books of Time Factors
• Books of Treatment Outcome